Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans

Pharmacology Biochemistry and Behavior

Volumn 87, Issue 1, 2007, Pages 20-29

  Stoops, William W ^a   Vansickel, Andrea R ^a,b   Lile, Joshua A ^a   Rush, Craig R ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Agonist pharmacotherapy; d Amphetamine; Human; Pretreatment; Progressive ratio; Reinforcement; Subject rated effects

Indexed keywords

DEXAMPHETAMINE; PLACEBO;

ADULT; AGONIST PHARMACOTHERAPY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; COCAINE DEPENDENCE; DOSE TIME EFFECT RELATION; DRUG CAPSULE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG EFFECT; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; METHAMPHETAMINE DEPENDENCE; NORMAL HUMAN; PERFORMANCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; QUESTIONNAIRE; RATING SCALE; REINFORCEMENT;

ADULT; AFFECT; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DATA INTERPRETATION, STATISTICAL; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; MALE; QUESTIONNAIRES; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION;

EID: 34249809118     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.03.016     Document Type: Article

References (50)

1. Abreu M.E., and Griffiths R.R. Drug tasting may confound human drug discrimination studies. Psychopharmacology 125 (1996) 255-257
2. Angrist B., Corwin J., Bartlik B., and Cooper T. Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects. Biol Psychiatry 22 (1987) 1357-1368
3. Barrett A.C., Miller J.R., Dohrmann J.M., and Caine S.B. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats. Neuropharmacology 47 Suppl 1 (2004) 256-273
4. Barrett S.P., Tichauer M., Leyton M., and Pihl R.O. Nicotine increases alcohol self-administration in non-dependent male smokers. Drug Alcohol Depend 81 (2006) 197-204
5. Bigelow G.E., Griffiths R.R., and Liebson I.A. Pharmacological influences upon human ethanol self-administration. Adv Exp Med Biol 85B (1977) 523-538
6. Chait L.D. Factors influencing the reinforcing and subjective effects of d-amphetamine in humans. Behav Pharmacol 4 (1993) 191-199
7. Chait L.D., Uhlenhuth E.H., and Johanson C.E. The discriminative stimulus and subjective effects of d-amphetamine in humans. Psychopharmacology 86 (1985) 307-312
8. Comer S.D., Haney M., Foltin R.W., and Fischman M.W. Amphetamine self-administration by humans: modulation by contingencies associated with task performance. Psychopharmacology 127 (1996) 39-46
9. Comer S.D., Collins E.D., and Fischman M.W. Choice between money and intranasal heroin in morphine maintained humans. Behav Pharmacol 8 (1997) 677-690
10. Comer S.D., Collins E.D., Wilson S.T., Donovan M.R., Foltin R.W., and Fischman M.W. Effects of an alternative reinforcer on intravenous heroin self-administration by humans. Eur J Pharmacol 345 (1998) 13-26
11. Comer S.D., Walker E.A., and Collins E.D. Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent subjects. Psychopharmacology 181 (2005) 664-675
12. de Wit H., and Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 75 (1981) 134-143
13. de Wit H., and Chutuape M.A. Increased ethanol choice in social drinkers following ethanol preload. Behav Pharmacol 4 (1993) 29-36
14. Donny E.C., Bigelow G.E., and Walsh S.L. Assessing the initiation of cocaine self-administration in humans during abstinence: effects of dose, alternative reinforcement, and priming. Psychopharmacology 172 (2004) 316-323
15. Fillmore M.T., Rush C.R., and Marczinski C.A. Effects of d-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies. Drug Alcohol Depend 71 (2003) 143-152
16. Fillmore M.T., Kelly T.H., and Martin C.A. Effects of d-amphetamine in human models of information processing and inhibitory control. Drug Alcohol Depend 77 (2005) 151-159
17. Foltin R.W., and Fischman M.W. Effects of buprenorphine on the self-administration of cocaine by humans. Behav Pharmacol 5 (1994) 79-89
18. Gerber G.J., and Stretch R. Drug-induced reinstatement of extinguished self-administration behavior in monkeys. Pharmacol Biochem Behav 3 (1975) 1055-1061
19. Grabowski J., Rhoades H., Schmitz J., Stotts A., Daruzska L.A., Creson D., et al. Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol 21 (2001) 522-526
20. Grabowski J., Rhoades H., Stotts A., Cowan K., Kopecky C., Dougherty A., et al. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 29 (2004) 969-981
21. Griffiths R.R., Bigelow G.E., and Liebson I.A. Reinforcing effects of caffeine in coffee and capsules. J Exp Anal Behav 52 (1989) 127-140
22. Haney M., Comer S.D., Ward A.S., Foltin R.W., and Fischman M.W. Factors influencing marijuana self-administration by humans. Behav Pharmacol 8 (1997) 101-112
23. Haney M., Hart C.L., and Foltin R.W. Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers. Neuropsychopharmacology 31 (2006) 1814-1821
24. Harrod S.B., Dwoskin L.P., Crooks P.A., Klebaur J.E., and Bardo M.T. Lobeline attenuates d-methamphetamine self-administration in rats. J Pharmacol Exp Ther 298 (2001) 172-179
25. Johnston L.D., O'Malley P.M., Bachman J.G., and Schulenberg J.E. Monitoring the future national survey results on drug use, 1975-2005. Volume I: Secondary school students (NIH Publication No. 06-5883) (2006), National Institute on Drug Abuse, Bethesda, MD
26. Kelly T.H., Foltin R.W., Emurian C.S., and Fischman M.W. Performance-based testing for drugs of abuse: dose and time profiles of marijuana, amphetamine, alcohol, and diazepam. J Anal Toxicol 17 (1993) 264-272
27. Kelly T.H., Robbins G., Martin C.A., Fillmore M.T., Lane S.D., Harrington N.G., et al. Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status. Psychopharmacology 189 (2006) 17-25
28. Lile J.A., Stoops W.W., Vansickel A.R., Glaser P.E.A., Hays L.R., and Rush C.R. Aripiprazole attenuates the discriminative-stimulus effects of d-amphetamine in humans. Neuropsychopharmacology 30 (2005) 2103-2114
29. Martin W.R., Sloan J.W., Sapira J.D., and Jasinski D.R. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12 (1971) 245-258
30. McCabe S.E., Knight J.R., Teter C.J., and Wechsler H. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 100 (2005) 96-106
31. McLeod D.R., and Griffiths R.R. Human progressive-ratio performance: maintenance by pentobarbital. Psychopharmacology 79 (1983) 4-9
32. Negus S.S., and Mello N.K. Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys. Drug Alcohol Depend 70 (2003) 39-52
33. Negus S.S., and Mello N.K. Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology 167 (2003) 324-332
34. Newman J.L., and Beardsley P.M. Effects of memantine, haloperidol, and cocaine on primary and conditioned reinforcement associated with cocaine in rhesus monkeys. Psychopharmacology 185 (2006) 142-149
35. Oliveto A.H., Bickel W.K., Hughes J.R., Shea P.J., Higgins S.T., and Fenwick J.W. Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J Pharmacol Exp Ther 261 (1992) 885-889
36. Oliveto A.H., McCance-Katz E., Singha A., Hameedi F., and Kosten T.R. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Behav Pharmacol 9 (1998) 207-217
37. Rush C.R., Kollins S.H., and Pazzaglia P.J. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans. Exp Clin Psychopharmacol 6 (1998) 32-44
38. Rush C.R., Essman W.D., Simpson C.A., and Baker R.W. Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing volunteers. J Clin Psychopharmacology 21 (2001) 273-286
39. Rush C.R., Stoops W.W., Hays L.R., Glaser P.E., and Hays L.S. Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. J Pharmacol Exp Ther 306 (2003) 195-204
40. Selzer M.L. The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument. Am J Psychiatry 127 (1971) 1653-1658
41. Shearer J., Sherman J., Wodak A., and Van Beek I. Substitution therapy for amphetamine users. Drug Alcohol Rev 21 (2002) 179-185
42. Shearer J., Wodak A., Mattick R.P., Van Beek I., Lewis J., Hall W., et al. Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence. Addiction 96 (2001) 1289-1296
43. Shearer J., Wodak A., van Beek I., Mattick R.P., and Lewis J. Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction 98 (2003) 1137-1141
44. Skinner H.A. The drug abuse screening test. Addict Behav 7 (1982) 363-371
45. Spiga R., Huang D.B., Meisch R.A., and Grabowski J. Human methadone self-administration: effects of diazepam pretreatment. Exp Clin Psychopharmacol 9 (2001) 40-46
46. Stoops W.W., Glaser P.E.A., Fillmore M.T., and Rush C.R. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. J Psychopharmacol 18 (2004) 534-543
47. Stoops W.W., Lile J.A., Fillmore M.T., Glaser P.E., and Rush C.R. Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration. Psychopharmacology 177 (2005) 349-355
48. Stoops W.W., Lile J.A., Fillmore M.T., Glaser P.E., and Rush C.R. Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology 182 (2005) 186-193
49. Stoops W.W., Lile J.A., Robbins C.G., Martin C.A., Rush C.R., and Kelly T.H. The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: Influence of sensation-seeking status. Addict Behav 32 (2007) 1177-1188
50. Walsh S.L., Haberny K.A., and Bigelow G.E. Modulation of intravenous cocaine effects by chronic oral cocaine in humans. Psychopharmacology 150 (2000) 361-373